2026 · 1st Quarter (Jan 1 - Mar 31)

AMGEN

Filed by ALPINE GROUP PARTNERS, LLC..

Open official filing

Source-reported fields

Filing overview

Type: 1st Quarter - Report
Posted: Apr 19, 2026
Income: $50,000.00
Expenses: Not reported
Registrant: ALPINE GROUP PARTNERS, LLC.
Client: AMGEN
Filing UUID: 7cde585c-478f-4489-aaa6-18e34de184d8
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

MMM · Medicare/Medicaid

Proposals related to drug pricing, drug price transparency, PBMs, the 340B program Implementation of the Inflation Reduction Act

TAX · Taxation/Internal Revenue Code

International tax developments

TRD · Trade (domestic/foreign)

Tariffs

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.